Godbold J - Search Results

1

Clinical pattern and risk factors for dyskinesias following fetal nigral transplantation in Parkinson's disease: a double blind video-based analysis.

Olanow CW, Gracies JM, Goetz CG, Stoessl AJ, Freeman T, Kordower JH, Godbold J, Obeso JA. Olanow CW, et al. Among authors: godbold j. Mov Disord. 2009 Feb 15;24(3):336-43. doi: 10.1002/mds.22208. Mov Disord. 2009. PMID: 19006186 Clinical Trial.

2

Sleepiness in Parkinson's disease: a controlled study.

Brodsky MA, Godbold J, Roth T, Olanow CW. Brodsky MA, et al. Among authors: godbold j. Mov Disord. 2003 Jun;18(6):668-72. doi: 10.1002/mds.10429. Mov Disord. 2003. PMID: 12784270

3

A double-blind controlled trial of bilateral fetal nigral transplantation in Parkinson's disease.

Olanow CW, Goetz CG, Kordower JH, Stoessl AJ, Sossi V, Brin MF, Shannon KM, Nauert GM, Perl DP, Godbold J, Freeman TB. Olanow CW, et al. Among authors: godbold j. Ann Neurol. 2003 Sep;54(3):403-14. doi: 10.1002/ana.10720. Ann Neurol. 2003. PMID: 12953276 Clinical Trial.

4

Selegiline and mortality in Parkinson's disease.

Olanow CW, Fahn S, Langston JW, Godbold J. Olanow CW, et al. Among authors: godbold j. Ann Neurol. 1996 Dec;40(6):841-5. doi: 10.1002/ana.410400605. Ann Neurol. 1996. PMID: 9007088 Review. No abstract available.

5

Use of placebo surgery in controlled trials of a cellular-based therapy for Parkinson's disease.

Freeman TB, Vawter DE, Leaverton PE, Godbold JH, Hauser RA, Goetz CG, Olanow CW. Freeman TB, et al. Among authors: godbold jh. N Engl J Med. 1999 Sep 23;341(13):988-92. doi: 10.1056/NEJM199909233411311. N Engl J Med. 1999. PMID: 10498497 No abstract available.

6

Effect of adding selegeline to levodopa in early, mild Parkinson's disease. Patients taking selegeline may have received more levodopa than necessary.

Olanow CW, Godbold JH, Koller W. Olanow CW, et al. Among authors: godbold jh. BMJ. 1996 Mar 16;312(7032):702-3; author reply 704-5. BMJ. 1996. PMID: 8597746 Free PMC article. No abstract available.

7

Toward the use of surgical placebo-controlled trials.

Freeman TB, Vawter D, Goetz CG, Leaverton PE, Hauser RA, Sanberg PR, Godbold JH, Olanow CW. Freeman TB, et al. Among authors: godbold jh. Transplant Proc. 1997 Jun;29(4):1925. doi: 10.1016/s0041-1345(97)00163-2. Transplant Proc. 1997. PMID: 9193457 No abstract available.

8

Transgressing the ventricular wall during subthalamic deep brain stimulation surgery for Parkinson disease increases the risk of adverse neurological sequelae.

Gologorsky Y, Ben-Haim S, Moshier EL, Godbold J, Tagliati M, Weisz D, Alterman RL. Gologorsky Y, et al. Among authors: godbold j. Neurosurgery. 2011 Aug;69(2):294-9; discussion 299-300. doi: 10.1227/NEU.0b013e318214abda. Neurosurgery. 2011. PMID: 21389886

9

A placebo-controlled trial of lamotrigine for painful HIV-associated neuropathy.

Simpson DM, Olney R, McArthur JC, Khan A, Godbold J, Ebel-Frommer K. Simpson DM, et al. Among authors: godbold j. Neurology. 2000 Jun 13;54(11):2115-9. doi: 10.1212/wnl.54.11.2115. Neurology. 2000. PMID: 10851374 Clinical Trial.

10

Complement component C3 allotypes and outcomes in liver transplantation.

Dhillon N, Walsh L, Krüger B, Mehrotra A, Ward SC, Godbold J, Radwan M, Schiano T, Murphy B, Schröppel B. Dhillon N, et al. Among authors: godbold j. Liver Transpl. 2010 Feb;16(2):198-203. doi: 10.1002/lt.21972. Liver Transpl. 2010. PMID: 20104494 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

201 results

Search Page

Filters